In the article titled “New Issues in the Management of Osteoporosis” [1], there was an error regarding the FRAX® tool, which should be clarified as follows.
The article notes, “It introduces and validates the Mikkeli Osteoporosis Index (MOI) and compares its performance to WHO FRAX tool in separate Finnish cohorts of postmenopausal women. The performance of MOI was found to be comparable to that of World Health Organization (WHO) FRAX-tool in identification of intervention thresholds.” However, the World Health Organization (WHO) did not develop, test, or endorse the FRAX tool or its recommendations [2]. The metabolic bone disease unit at the University of Sheffield that developed FRAX was a WHO Collaborating Centre from 1991 to 2010, but treatment guidelines must undergo a formal process before they can be endorsed by the WHO.
References
- 1.Sirola J., Curiel M. D., Honkanen R., Iwamoto J. New issues in the management of osteoporosis. Journal of Osteoporosis. 2011;2011:1. doi: 10.4061/2011/582789.582789 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Ford N., Norris S. L., Hill S. R. Clarifying WHO’s position on the FRAX® tool for fracture prediction. Bulletin of the World Health Organization. 2016;94(12):p. 862. doi: 10.2471/BLT.16.188532. [DOI] [PMC free article] [PubMed] [Google Scholar]